Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
38 studies found for:    "Human T-cell leukemia virus type 1"
Show Display Options
Rank Status Study
1 Not yet recruiting Influence of IL28B Genetic Variation on the Phenotype Infection of HTLV-1
Condition: HTLV-I Infections
Intervention:
2 Completed Recombinant Human Interferon Beta-1a (Avonex) for the Treatment of Patients With HTLV-1-Associated Myelopathy (HAM)
Conditions: HTLV-I Infection;   Spinal Cord Disease;   Tropical Spastic Paraparesis
Intervention: Drug: Recombinant human interferon beta-1a
3 Suspended Hu Mik-Beta-1 to Treat HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
Condition: HTLV-1
Intervention: Drug: Hu MiK-Beta-1
4 Enrolling by invitation Urological Physical Therapy in HTLV-1 With Urinary Symptoms
Conditions: Tropical Spastic Paraparesis;   HTLV-1
Intervention: Procedure: Urological physical therapy
5 Unknown  Use of Pentoxifylline in Human T-lymphotropic Virus Type-1 (HTLV-1) Diseases
Conditions: HTLV-1;   Tropical Spastic Paraparesis;   Immune System Diseases;   Physical Disability;   Pentoxifylline
Interventions: Drug: Pentoxifylline;   Drug: Placebo
6 Completed Zidovudine Plus Lamivudine in HTLV-I-Associated Myelopathy: a Randomised Trial
Condition: HTLV-I-Associated Myelopathy
Intervention: Drug: Zidovudine/lamivudine
7 Enrolling by invitation Evaluation of the MP Diagnostics HTLV Blot 2.4
Conditions: HTLV-I Infections;   HTLV-II Infections;   Human T-lymphotropic Virus 1;   Human T-lymphotropic Virus 2;   HTLV I Associated T Cell Leukemia Lymphoma;   HTLV I Associated Myelopathies
Intervention: Other: CDPHL Algorithm
8 Unknown  Efficacy and Safety of Tamibarotene(AM80H) for HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP)
Condition: HTLV-I-Associated Myelopathy
Intervention: Drug: Tamibarotene
9 Recruiting Evaluation of Patients With HAM/TSP
Conditions: HTLV-I Infection;   Tropical Spastic Paraparesis
Intervention:
10 Active, not recruiting Trial to Assess Effect of Raltegravir on HTLV-1 Proviral Load
Condition: Human T-cell Leukemia Virus Type 1 Infection
Intervention: Drug: Raltegravir
11 Completed Ciclosporin in HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP)
Condition: HTLV I Associated Myelopathy
Intervention: Drug: ciclosporin
12 Completed Natural History of HTLV-I Infection: Prospective Follow-up of a Cohort of Blood Donors in Jamaica
Condition: HTLV-I
Intervention:
13 Recruiting Raltegravir for HAM/TSP
Conditions: HAM/TSP;   HTLV-1
Intervention: Drug: Raltegravir
14 Completed Assessment of Patients With Multiple Sclerosis (MS)
Conditions: Herpesviridae Infection;   HTLV-I Infection;   Multiple Sclerosis;   Tropical Spastic Paraparesis;   Vasculitis
Intervention:
15 Completed
Has Results
Anti-Tac for Treatment of Leukemia
Conditions: HTLV-I Infection;   T Cell Leukemia
Intervention: Biological: daclizumab
16 Completed A Study of Familial and Genetic Aspects of Adult T-Cell: Leukemia/Lymphoma , Tropical Spastic Paraparesis, and Infective Dermatitis
Condition: HTLV-I
Intervention:
17 Terminated The HAM Infliximab Study
Condition: HTLV-I-associated Myelopathy
Intervention: Drug: Infliximab
18 Completed MRI Brain Studies in Patients With HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis
Condition: Tropical Spastic Paraparesis
Intervention:
19 Completed Pilot Study of Combination Therapy With CHOP-Zenapax (CHOP-daclizumab)
Condition: HTLV-I Associated Adult T-cell Leukaemia/Lymphoma (ATLL)
Intervention: Drug: CHOP-daclizumab
20 Terminated Safety and Efficiency Study of Valproic Acid In HAM/TSP
Condition: HTLV-I-Associated Myelopathy
Intervention: Drug: Valproic Acid

   Previous Page Studies Shown (1-20) Next Page (21-38) Show next page of results    Last Page
Indicates status has not been verified in more than two years